Clinical Trial Update: Ashwagandha for Cognitive Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Ashwagandha targeting cognitive dysfunction associated with chemotherapy (chemo fog).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Cognitive Impairment

Drugs mentioned

• Ashwagandha (Withania somnifera)

Snippet

Sponsor: Sutter Health | Conditions: Chemo Fog | Phase 2 | Status: UNKNOWN